Depression and smoking: mediating role of vagal tone and inflammation (Q44661231)

5 December 2017

Depression and smoking: mediating role of vagal tone and inflammation (English)

1 reference

5 December 2017

2

Adrian Loerbroks

1 reference

5 December 2017

6

Julian F Thayer

1 reference

5 December 2017

Laine Taylor

1

1 reference

5 December 2017

Raphael M Herr

series ordinal

3

1 reference

5 December 2017

Richard D Lane

series ordinal

4

1 reference

5 December 2017

Joachim E Fischer

series ordinal

5

1 reference

5 December 2017

1 December 2011

1 reference

Annals of Behavioral Medicine

5 December 2017

1 reference

5 December 2017

42

1 reference

5 December 2017

3

1 reference

5 December 2017

334-340

1 reference

Psychiatric disorders and stages of smoking

5 December 2017

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

21 January 2018

The inflammatory reflex

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Cigarette smoking and heart rate variability: dynamic influence of parasympathetic and sympathetic maneuvers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Beyond heart rate variability: vagal regulation of allostatic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Cardiac vagal control in depression: a critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

A global view of twenty years of Brain, Behavior, and Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Physiology of psychoneuroimmunology: a personal view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Depressive disorders and immunity: 20 years of progress and discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Heart rate variability in depressive and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Immunomodulatory effects of cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Systemic effects of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Physiology and immunology of the cholinergic antiinflammatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

The relationship between heart rate variability and inflammatory markers in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Nighttime vagal cardiac control and plasma fibrinogen levels in a population of working men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Heart rate variability: Standards of measurement, physiological interpretation, and clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: effects of various respiratory patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Sample size for studying intermediate endpoints within intervention trails or observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

A comparison of methods to test mediation and other intervening variable effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

The California Tobacco Control Program and potential harm reduction through reduced cigarette consumption in continuing smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Smoking, nicotine and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Mood disorders in the medically ill: scientific review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12160-011-9288-7

10.1007/S12160-011-9288-7

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference